首页> 外国专利> Medicament composition for suppression of t-cell proliferation and immune response against introduction of non-self tissue containing major histocompatibility complex class ii antigens or synthetic peptides corresponding to class ii antigens

Medicament composition for suppression of t-cell proliferation and immune response against introduction of non-self tissue containing major histocompatibility complex class ii antigens or synthetic peptides corresponding to class ii antigens

机译:用于抑制t细胞增殖和针对引入非自身组织的免疫组合物的药物组合物,所述非自身组织包含主要组织相容性复合物ii类抗原或对应于ii类抗原的合成肽

摘要

Described are methods for: (a) suppressing the ability of T-cells from a mammal to proliferate in response to stimulation by nonself mammalian tissue; and (b) suppressing immune response which leads to allograft rejection in a mammal receiving an allograft from a donor mammal. The methods involve orally administering to the mammal to be thus treated a composition comprising at least one of: (i) a major histocompatibility complex Class II antigen from a second nonself mammal or from tissue of a mammal syngeneic to said nonself mammal; (ii) at least one synthetic peptide corresponding to a T-cell suppressive fragment of said Class II antigen, said composition being administered in an amount effective to suppress said proliferation. The foregoing compositions are also described.
机译:描述了用于以下方面的方法:(a)抑制哺乳动物的T细胞响应非自身哺乳动物组织的刺激而增殖的能力; (b)抑制免疫应答,该免疫应答导致在从供体哺乳动物接受同种异体移植的哺乳动物中导致同种异体移植排斥。所述方法包括向要治疗的哺乳动物口服施用包含以下至少一种的组合物:(i)来自第二非本人哺乳动物或与所述非本人哺乳动物同属的哺乳动物的组织的主要组织相容性复合物II类抗原; (ii)对应于所述II类抗原的T细胞抑制片段的至少一种合成肽,以有效抑制所述增殖的量施用所述组合物。还描述了前述组合物。

著录项

  • 公开/公告号IL105472A

    专利类型

  • 公开/公告日1999-06-20

    原文格式PDF

  • 申请/专利权人 AUTOIMMUNE INC.;

    申请/专利号IL19930105472

  • 发明设计人

    申请日1993-04-20

  • 分类号A61K35/14;A61K38/00;A61K39/00;

  • 国家 IL

  • 入库时间 2022-08-22 02:27:14

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号